FATE:Fate Therapeutics Inc Snapshot | Charting | News | Options
$4.54   0.00%  $0.00 NASDAQ 4:30p ET
April 22 '24 		Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Dis... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
     GlobeNewswire
    Full Story →

    Headline News
    NOTICE TO LONG-TERM SHAREHOLDERS OF FATE THERAPEUTICS, INC. (FATE): GRABAR LAW OFFICE IS INVESTIGATING CLAIMS ON YOUR BEHALF
    3:31a ET April 5 '24 Newsfile Corp
    Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
    8:00a ET April 3 '24 GlobeNewswire
    Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
    4:01p ET April 2 '24 GlobeNewswire
    More News →
    Day  0.00%Week  13.85%Month  33.92%More Charting →
    April 23 '24. Markets Closed.
    Last $4.54
    Day change   0.00%$0.00
    Open $4.79
    Gap at open $0.25
    Previous close $4.54
    Trading volume 4,022,308
    10 Day avg vol. 2,424,774
    Shares out. 113.2Mil
    Market cap. $513.8Mil
    Trading activity Above Avg.
    Previous data from yesterday, April 22 '24.

    Historical Price Performance
    3 month   0.44% 
    6 month   175% 
    1 year   24.71% 
    2 year   87.19% 

    Earnings
    Previous 12m -$1.63
    Next 12m Estimate -$1.96
    P/E ratio 2.8x
    Revenue 64Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.